Key facts
- This page summarizes David Bench's Form 4 filing for ENZO BIOCHEM INC (ENZB).
- 1 reported transaction and 4 derivative rows are listed below.
- Accepted by SEC: 28 Mar 2022, 17:31.
David Bench - 24 Mar 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)
- Reporting relationship
- CFO, SVP, Treasurer and CS
- Issuer ticker
- ENZB
- Reported as of
- 24 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2022, 17:31:00 UTC
- Prior SEC filing
- 15 Feb 2022
- Next SEC filing
- 14 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Bench
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Bench filed Form 4 for ENZO BIOCHEM INC (ENZB) on 28 Mar 2022.
Change
- Previous filing in this sequence was filed on 15 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENZ
holding
Common Stock, $0.01 Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,138
- Date
- 24 Mar 2022
- Ownership
- 401k
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ENZ
transaction
Derivative
Stock Option (to acquire Common Stock)
Award
- Transaction value
- $0
- Shares
- +87,500
- Change %
- Price
- $0.000000
- Shares after
- 87,500
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,500
- Exercise price
- $2.98
- Footnotes
- F2
ENZ
holding
Derivative
Stock Option (to acquire Common Stock)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 87,500
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,500
- Exercise price
- $3.36
- Footnotes
- F2
ENZ
holding
Derivative
Stock Option (to acquire Common Stock)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 55,400
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,400
- Exercise price
- $2.63
- Footnotes
- F2
ENZ
holding
Derivative
Stock Option (to acquire Common Stock)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 55,400
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,400
- Exercise price
- $2.20
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
Footnote F2
The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.